<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Three children with <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> developed severe neurotoxicity, including transient <z:hpo ids='HP_0100704'>cortical blindness</z:hpo>, following chemotherapy regimens </plain></SENT>
<SENT sid="1" pm="."><plain>The only drug in common was <z:chebi fb="0" ids="28445">vincristine</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The clinical courses of these patient are described </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> have completely recovered, although one child who was rechallenged with <z:chebi fb="0" ids="28445">vincristine</z:chebi> had a <z:hpo ids='HP_0006543'>cardiorespiratory arrest</z:hpo>, increasing neurotoxicity, and recurrence of <z:hpo ids='HP_0000618'>blindness</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Transient <z:hpo ids='HP_0100704'>cortical blindness</z:hpo> has not previously been attributed to <z:chebi fb="0" ids="28445">vincristine</z:chebi> <z:chebi fb="0" ids="16189">sulfate</z:chebi> therapy, but must be considered as a possible complication of treatment with this agent </plain></SENT>
</text></document>